Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Carrier

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cornell Law Review|December 14, 2017
Sharing, samples, and generics: an antitrust frameworkMichael A Carrier
Michigan Law Review|June 12, 2010
Unsettling drug patent settlements: a framework for presumptive illegalityMichael A Carrier
The Journal of Legal Medicine|September 11, 2019
Higher Drug Prices from Anticompetitive Conduct: Three Case StudiesMichael A Carrier
Journal of Law and the Biosciences|May 27, 2021
Pharmaceutical antitrust enforcement in the United States and ChileMichael A Carrier, Fernando Araya
JAMA|May 26, 2018
Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical IndustryMichael S Sinha, Gregory D Curfman, Michael A Carrier
Blood|January 29, 2016
Strategies that delay or prevent the timely availability of affordable generic drugs in the United StatesGregory H Jones, Michael A Carrier, Richard T Silver, et al.
Chest|February 26, 2023
Patenting Strategies on Inhaler Delivery DevicesBrandon J Demkowicz, S Sean Tu, Aaron S Kesselheim, et al.
JAMA Internal Medicine|October 18, 2021
Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part DStacie B Dusetzina, Ameet Sarpatwari, Michael A Carrier, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cornell Law Review|December 14, 2017
Sharing, samples, and generics: an antitrust frameworkMichael A Carrier
Michigan Law Review|June 12, 2010
Unsettling drug patent settlements: a framework for presumptive illegalityMichael A Carrier
The Journal of Legal Medicine|September 11, 2019
Higher Drug Prices from Anticompetitive Conduct: Three Case StudiesMichael A Carrier
Journal of Law and the Biosciences|May 27, 2021
Pharmaceutical antitrust enforcement in the United States and ChileMichael A Carrier, Fernando Araya
JAMA|May 26, 2018
Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical IndustryMichael S Sinha, Gregory D Curfman, Michael A Carrier
Blood|January 29, 2016
Strategies that delay or prevent the timely availability of affordable generic drugs in the United StatesGregory H Jones, Michael A Carrier, Richard T Silver, et al.
Chest|February 26, 2023
Patenting Strategies on Inhaler Delivery DevicesBrandon J Demkowicz, S Sean Tu, Aaron S Kesselheim, et al.
JAMA Internal Medicine|October 18, 2021
Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part DStacie B Dusetzina, Ameet Sarpatwari, Michael A Carrier, et al.
Pageof 1